These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 9051292

  • 1. Inhibition by rapamycin of ornithine decarboxylase and epithelial cell proliferation in intestinal IEC-6 cells in culture.
    Seidel ER, Ragan VL.
    Br J Pharmacol; 1997 Feb; 120(4):571-4. PubMed ID: 9051292
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of ornithine decarboxylase activity but not expression of the gene by cimetidine in intestinal mucosal cells.
    Wang JY, McCormack SA, Viar MJ, Johnson LR.
    J Pharmacol Exp Ther; 1995 Jul; 274(1):521-9. PubMed ID: 7616440
    [Abstract] [Full Text] [Related]

  • 3. Anti-IgM-induced growth inhibition and apoptosis are independent of ornithine decarboxylase in Ramos cells.
    Lin CK, Zou HY, Kaptein JS, Yen CF, Kalunta CI, Nguyen TT, Park E, Lad PM.
    Exp Cell Res; 1997 Nov 25; 237(1):231-41. PubMed ID: 9417887
    [Abstract] [Full Text] [Related]

  • 4. Phosphatidylinositol 3-kinase is required for the induction of ornithine decarboxylase in leukemia cells stimulated to growth.
    Flamigni F, Marmiroli S, Capanni C, Stefanelli C, Guarnieri C, Caldarera CM.
    Biochem Biophys Res Commun; 1997 Oct 29; 239(3):729-33. PubMed ID: 9367837
    [Abstract] [Full Text] [Related]

  • 5. Gastrin induces phosphorylation of eIF4E binding protein 1 and translation initiation of ornithine decarboxylase mRNA.
    Pyronnet S, Gingras AC, Bouisson M, Kowalski-Chauvel A, Seva C, Vaysse N, Sonenberg N, Pradayrol L.
    Oncogene; 1998 Apr 30; 16(17):2219-27. PubMed ID: 9619831
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. FK 506, rapamycin, and cyclosporine: effects on IL-4 and IL-10 mRNA levels in a T-helper 2 cell line.
    Wang SC, Zeevi A, Jordan ML, Simmons RL, Tweardy DJ.
    Transplant Proc; 1991 Dec 30; 23(6):2920-2. PubMed ID: 1721312
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The hydroxylamine of sulfamethoxazole synergizes with FK506 and cyclosporin A, inhibiting T-cell proliferation.
    Hess DA, Bird IA, Almawi WY, Rieder MJ.
    J Pharmacol Exp Ther; 1997 Apr 30; 281(1):540-8. PubMed ID: 9103542
    [Abstract] [Full Text] [Related]

  • 10. Osteoblastic differentiation is enhanced by rapamycin in rat osteoblast-like osteosarcoma (ROS 17/2.8) cells.
    Ogawa T, Tokuda M, Tomizawa K, Matsui H, Itano T, Konishi R, Nagahata S, Hatase O.
    Biochem Biophys Res Commun; 1998 Aug 10; 249(1):226-30. PubMed ID: 9705862
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Differential effects of rapamycin, cyclosporine A, and FK506 on human coronary artery smooth muscle cell proliferation and signalling.
    Hafizi S, Mordi VN, Andersson KM, Chester AH, Yacoub MH.
    Vascul Pharmacol; 2004 Aug 10; 41(4-5):167-76. PubMed ID: 15607500
    [Abstract] [Full Text] [Related]

  • 16. Calcium stimulates ornithine decarboxylase activity in cultured mammalian epithelial cells.
    Langdon RC, Fleckman P, McGuire J.
    J Cell Physiol; 1984 Jan 10; 118(1):39-44. PubMed ID: 6690450
    [Abstract] [Full Text] [Related]

  • 17. [Mechanism of action of the new immunosuppressants: cyclosporin A, FK 506 and rapamycin].
    Rondeau E.
    Nephrologie; 1992 Jan 10; 13(3):137. PubMed ID: 1379348
    [No Abstract] [Full Text] [Related]

  • 18. Apparent post-transcriptional modification of ornithine decarboxylase accounts for its induction in IEC-6 cells in culture.
    Seidel ER, Ginty DD.
    Digestion; 1990 Jan 10; 46 Suppl 2():383-9. PubMed ID: 2262070
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Anti-tumor activity of antizyme which targets the ornithine decarboxylase (ODC) required for cell growth and transformation.
    Iwata S, Sato Y, Asada M, Takagi M, Tsujimoto A, Inaba T, Yamada T, Sakamoto S, Yata J, Shimogori T, Igarashi K, Mizutani S.
    Oncogene; 1999 Jan 07; 18(1):165-72. PubMed ID: 9926931
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.